Results for tag: "Cholera Drug"

The Cholera Drug market is a subset of the larger Infectious Diseases Drugs market. Cholera is an acute diarrheal infection caused by the bacterium Vibrio cholerae. Cholera drugs are used to treat the symptoms of the disease, such as dehydration, electrolyte imbalance, and acidosis. These drugs are typically administered orally or intravenously, depending on the severity of the infection. Commonly used cholera drugs include antibiotics, antidiarrheals, and rehydration solutions. The Cholera Drug market is highly competitive, with many companies offering a variety of products. Major players in the market include Merck & Co., Pfizer, GlaxoSmithKline, Sanofi, and Novartis. Other companies in the market include Cipla, Lupin, and Sun Pharmaceuticals. Show Less Read more